Navigation Links
Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
Date:10/18/2007

er

and first nine months of $63,265 and $202,048, respectively, compared

with $60,630 and $193,864 for the prior year.

(2) The average number of common shares outstanding for diluted earnings

per share is higher than for basic earnings per share due to the

assumed conversion of the Company's outstanding convertible senior

debentures, outstanding stock options, deferred contingent common

stock awards, restricted stock awards and convertible preferred stock

into common stock equivalents using the treasury stock method. For

purposes of calculating diluted earnings per share, interest expense,

net of capitalized interest and taxes related to the Company's

outstanding convertible senior debentures is added back to reported

net income, and the additional common shares (assuming conversion) are

included in total shares outstanding. Interest expense, net of

capitalized interest and taxes was $7,838 and $23,617 for the 2007

third quarter and first nine months, respectively, compared with

$8,100 and $21,841 for the 2006 third quarter and first nine months,

respectively.

(3) Charges related to activities associated with the Company's

productivity initiatives and the 2006 income tax adjustment are

considered certain significant items and have been excluded from the

results of operations - as adjusted for the 2007 and 2006 third

quarter and first nine months as follows:

Productivity Initiatives

(UNAUDITED)

Three Months Ended Nine Months Ended

(In thousands, except

per share amounts) 9/30/2007 9/30/2006 9/30/2007 9/30/2006

Cost of Goods Sold $111,200 $31,300 $182,400 $86,500

Selling, General
'/>"/>

SOURCE Wyeth
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy
3. Wyeth Pharma Wins Law Suit
4. Verdict Against Wyeth Pharma in Prempro Case
5. FDA Approves Wyeths Oral Contraceptive Lybrel
6. Autopsy reports could be valuable and informative
7. China reports declining number of SARS Cases
8. Russia Reports First SARS Case
9. Research reports that c-section deliveries are rising
10. Jharkhand reports 13,000 Malaria cases
11. Uganda Reports Failure To Contain Sleeping Sickness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Adam DreamHealer’s Glo...aling intentions changes the physiology of someone...ing intentions at a time unknown to a volunteer wh...s analyzed by world experts in the USA and Canada....November 25, 2009 -- Adam DreamHealer’s Gl...
(Date:11/25/2009)... Vintners and guests, generos..., Hillsboro, OR (PRWEB) No...! The Oregon Pinot Noir Auction topped $607,700 ...November 13 and 14. Spurred by the Big Board aucti...raised close to $14,000 above 2008 totals, over 40...
(Date:11/25/2009)..., LONDON,November25/PRNewswire/--Therearemanyway...angivebigresults.Butthere,alwaysseemstobeconflicti...toimproveourhealth. , So,therealbuzz.comteamh...evetobeprettymuchincontrovertible!Doingacombinatio...proveyourlifestyle,andwell-being-sotrythemout. ,...
(Date:11/24/2009)...-call radiology residents generally provide accura...diology CT scans after hours when attending neuror...large study performed at a level I trauma center p...the American College of Radiology ( JACR ). , ...ssential element of diagnostic radiology. In most ...
(Date:11/24/2009)..., OXFORD,EnglandandSANDIEGO,Nov.24/PRNewswire/--...of-caremoleculardiagnosticscompany,announcedtodayf..., Dr.JorgeGarceswillleadtheUSteamasPresidentand...inancialOfficer,USA.StationedatEnigma,snewU.S.head...xpandrapidlywitharecruitmentprogrammeplannedforass...
Breaking Medicine News(10 mins):Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 3Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3
...ps patients with bladder cancer live longer, accor...ho receive chemotherapy plus surgery //survive lon...all this an important advance in the treatment of ... Cancer Society, approximately 57,000 people will ...
...ay want to leave the alcohol at home next time you...unburn.Researchers found those who consumed //alco...drinkers and were more likely to need a pain relie...rs. However, drinkers did not report spending more...
...ty should be the treatment of choice for heart att...//go to doesn't offer angioplasty services and the...reatment. Research has shown heart attack patie...ot-busting drug therapy called fibrinolysis. Da...
...f heart disease may be present early in life, say ...between body mass index and C-reactive //protein l...r for cardiovascular disease in adults. Resea...l S. Ford, M.D., M.P.H., from the Centers for Dise...
...rt taking painkillers during pregnancy increases t...atory drugs, which include// aspirin and ibuprofen...ften used by pregnant women. Doctors interview...e pregnant, reproductive history, and potential ri...
...earchers say giving heroin to opiate addicts can h...archers in the Netherlands conducted two separate ...t respond to methadone maintenance treatment. Part...er 12 months of methadone treatment alone, 12 mont...
Other Medicine News:
(Date:11/24/2009)...iencesCorporationannouncedtodaythattherewillbemult...ationFLT3inhibitor,inAMLatthe51stAmericanSocietyof...A,December5-8,2009.Anoralpresentationwillhighlight...ystudyinadultswithacutemyeloidleukemia(AML).Additi...eeffectofAC220monotherapyandincombinationwithchemo...
(Date:11/24/2009)...irstCall/--CardioGenicsHoldingsInc.(OTCBulletinBoa...gtheimmunoassaysegmentoftheIVDtestingmarket,report...tothenextphaseofthecommercializationofCardioGenics.... ,, PertheagreementwithMerckChimiethatwasexecu...withitsproprietarysilvercoatedparamagneticbeadsfor...
(Date:11/24/2009)...all/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECTE)...ystemasanon-invasive,wireless,transdermalcontinuou...nPrepSystemfortransdermaldrugdelivery,announcedtod...veOfficer,willpresentatthe13thAnnualBiotechandSpec...rkSocietyofSecuritiesAnalysts,at2:05onDecember1,20...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Does Diabetes Slow Alzheimers 3F 60110 1Does Diabetes Slow Alzheimers 3F 60110 2Heart Disease Gender Gap Narrows 60108 1Heart Disease Gender Gap Narrows 60108 2Heart Disease Gender Gap Narrows 60108 3Deadly stomach infection rising in community settings Mayo Clinic study finds 60106 1Deadly stomach infection rising in community settings Mayo Clinic study finds 60106 2
...c. 2 A study has found that positron emission mam...east, is not affected by either breast density or ...the effectiveness of standard mammography and MRI ...ay at the annual meeting of the Radiological Socie... of PEM to detect cancer does not appear to be adv...
...Pte Ltd today announced the initiation of a Phase ...active JAK2 inhibitor, in leading medical centers ...myelofibrosis (CIMF). , , The trial is desig...518 in patients with CIMF and is expected to enrol... will assess the safety profile and evaluate the p...
Other Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3